Integral Health Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-300,000
Closed -$17.9M – 91
2021
Q3
$17.9M Buy
300,000
+75,000
+33% +$4.43M 5.14% 1
2021
Q2
$15.3M Buy
225,000
+15,000
+7% +$978K 4.22% 3
2021
Q1
$14.6M Buy
210,000
+10,000
+5% +$769K 4.16% 3
2020
Q4
$15.4M Buy
200,000
+50,000
+33% +$3.75M 4.57% 3
2020
Q3
$11.2M Sell
150,000
-25,000
-14% -$1.67M 3.43% 5
2020
Q2
$11M Buy
175,000
+65,000
+59% +$3.58M 3.3% 4
2020
Q1
$4.62M Buy
110,000
+40,000
+57% +$1.83M 2.04% 20
2019
Q4
$3.18M Buy
+70,000
New +$3.31M 1.24% 27

Other funds holding ARNA

Integral Health Asset Management's ARNA Position: Q4 2021 in Review

Integral Health Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 300,000 shares — an estimated $17.9M sold.

Integral Health Asset Management first reported a position in ARNA in Q4 2019 and held it in 8 quarters. The position peaked at $17.9M in Q3 2021. 317 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Integral Health Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Integral Health Asset Management sold 300,000 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $17.9M.
  • Integral Health Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 8 quarters.
  • Integral Health Asset Management's Arena Pharmaceuticals Inc position peaked at $17.9M in Q3 2021.
  • 317 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.